175 related articles for article (PubMed ID: 32715405)
1. Practices and opinions about disclosure of the diagnosis of Alzheimer's disease to patients with MCI or dementia: a survey among Belgian medical experts in the field of dementia.
Mormont E; Bier JC; Bruffaerts R; Cras P; De Deyn P; Deryck O; Engelborghs S; Petrovic M; Picard G; Segers K; Thiery E; Versijpt J; Hanseeuw B
Acta Neurol Belg; 2020 Oct; 120(5):1157-1163. PubMed ID: 32715405
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease diagnosis disclosure in Brazil: a survey of specialized physicians' current practice and attitudes.
Raicher I; Shimizu MM; Takahashi DY; Nitrini R; Caramelli P
Int Psychogeriatr; 2008 Jun; 20(3):471-81. PubMed ID: 17822571
[TBL] [Abstract][Full Text] [Related]
3. Perspectives of patients, care partners, and primary care physicians on management of mild cognitive impairment and mild Alzheimer's disease dementia.
Brunton S; Pruzin JJ; Alford S; Hamersky C; Sabharwal A; Gopalakrishna G
Postgrad Med; 2023 Jun; 135(5):530-538. PubMed ID: 37219410
[TBL] [Abstract][Full Text] [Related]
4. Understanding the role of psychiatrists in the diagnosis and management of mild cognitive impairment and mild Alzheimer's disease dementia: a cross-sectional survey.
Gopalakrishna G; Brunton S; Pruzin J; Alford S; Hamersky C; Sabharwal A
BMC Psychiatry; 2023 Oct; 23(1):716. PubMed ID: 37794326
[TBL] [Abstract][Full Text] [Related]
5. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
[TBL] [Abstract][Full Text] [Related]
6. Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey.
Bertens D; Vos S; Kehoe P; Wolf H; Nobili F; Mendonça A; van Rossum I; Hort J; Molinuevo JL; Heneka M; Petersen R; Scheltens P; Visser PJ
Alzheimers Res Ther; 2019 Aug; 11(1):74. PubMed ID: 31439020
[TBL] [Abstract][Full Text] [Related]
7. Measurement of CSF α-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer's disease.
García-Ayllón MS; Monge-Argilés JA; Monge-García V; Navarrete F; Cortés-Gómez MA; Sánchez-Payá J; Manzanares J; Gasparini-Berenguer R; Leiva-Santana C; Sáez-Valero J
J Neurochem; 2019 Jul; 150(2):218-230. PubMed ID: 31077373
[TBL] [Abstract][Full Text] [Related]
8. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
[TBL] [Abstract][Full Text] [Related]
9. Medical Journey of Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia: A Cross-sectional Survey of Patients, Care Partners, and Neurologists.
Pruzin JJ; Brunton S; Alford S; Hamersky C; Sabharwal A; Gopalakrishna G
J Prev Alzheimers Dis; 2023; 10(2):162-170. PubMed ID: 36946442
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
11. 2022 Alzheimer's disease facts and figures.
Alzheimers Dement; 2022 Apr; 18(4):700-789. PubMed ID: 35289055
[TBL] [Abstract][Full Text] [Related]
12. Experiences of the patients and their caregivers regarding the disclosure of the diagnosis of Alzheimer's disease: a Belgian retrospective survey.
Mormont E; de Fays K; Jamart J
Acta Neurol Belg; 2012 Sep; 112(3):249-54. PubMed ID: 22527789
[TBL] [Abstract][Full Text] [Related]
13. Caregivers' attitude toward disclosure of Alzheimer's disease diagnosis in Urban China.
Zou Y; Song N; Hu YB; Gao Y; Zhang YQ; Zhao QH; Guo QH; Li X; Li GJ; Xiao SF; Chen SD; Ren RJ; Wang G
Int Psychogeriatr; 2017 Nov; 29(11):1849-1855. PubMed ID: 28660845
[TBL] [Abstract][Full Text] [Related]
14. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
15. What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France.
Cognat E; Mouton Liger F; Troussière AC; Wallon D; Dumurgier J; Magnin E; Duron E; Gabelle A; Croisile B; de la Sayette V; Jager A; Blanc F; Bouaziz-Amar E; Miguet-Alfonsi C; Quillard M; Schraen S; Philippi N; Beaufils E; Pasquier F; Hannequin D; Robert P; Hugon J; Paquet C;
BMJ Open; 2019 May; 9(5):e026380. PubMed ID: 31152032
[TBL] [Abstract][Full Text] [Related]
16. Communication about diagnosis, prognosis, and prevention in the memory clinic: perspectives of European memory clinic professionals.
Hendriksen HMA; van Gils AM; van Harten AC; Hartmann T; Mangialasche F; Kamondi A; Kivipelto M; Rhodius-Meester HFM; Smets EMA; van der Flier WM; Visser LNC
Alzheimers Res Ther; 2023 Aug; 15(1):131. PubMed ID: 37543608
[TBL] [Abstract][Full Text] [Related]
17. Prediction and Early Detection of Alzheimer's Dementia: Professional Disclosure Practices and Ethical Attitudes.
Schweda M; Kögel A; Bartels C; Wiltfang J; Schneider A; Schicktanz S
J Alzheimers Dis; 2018; 62(1):145-155. PubMed ID: 29439325
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
[TBL] [Abstract][Full Text] [Related]
19. Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey.
Frederiksen KS; Nielsen TR; Appollonio I; Andersen BB; Riverol M; Boada M; Ceccaldi M; Dubois B; Engelborghs S; Frölich L; Hausner L; Gabelle A; Gabryelewicz T; Grimmer T; Hanseeuw B; Hort J; Hugon J; Jelic V; Koivisto A; Kramberger MG; Lebouvier T; Lleó A; de Mendonça A; Nobili F; Ousset PJ; Perneczky R; Olde Rikkert M; Robinson D; Rouaud O; Sánchez E; Santana I; Scarmeas N; Sheardova K; Sloan S; Spiru L; Stefanova E; Traykov L; Yener G; Waldemar G
Int J Geriatr Psychiatry; 2021 Feb; 36(2):324-333. PubMed ID: 32896040
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N
Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
